$GRST
ETHEMA HEALTH Corp Stock $grst

$grst Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000190359622000529 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$1.425M	$1.138M	$889.2K
YoY Change	64.46%	1083.5%	967.22%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.033M	$952.0K	$976.2K
YoY Change	66.26%	-38334.14%	1084.17%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$136.6K	$134.2K	$134.2K
YoY Change	8.46%	305.56%	352.02%
% of Gross Profit
Operating Expenses	$1.170M	$1.086M	$1.110M
YoY Change	56.52%	3448.28%	890.35%
Operating Profit	$255.0K	$51.76K
YoY Change	114.34%	-21.03%
Interest Expense	$198.4K	-$207.7K	$540.6K
YoY Change	-89.94%	-91.64%	-96.39%
% of Operating Profit	77.82%	-401.3%
Other Income/Expense, Net	-$1.045K	$1.045K	$1.154M
YoY Change	-99.82%		97727.12%
Pretax Income	$556.7K	-$154.9K	$1.631M
YoY Change	-63.12%	-94.1%	-88.85%
Income Tax	$44.65K	$24.70K	-$262.1K
% Of Pretax Income	8.02%		-16.08%
Net Earnings	$512.1K	-$193.8K	$1.901M
YoY Change	-66.98%	-92.62%	-87.0%
Net Earnings / Revenue	35.94%	-17.03%	213.79%
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00	-$51.97	$562.20
COMMON SHARES
Basic Shares Outstanding	3.729B shares
Diluted Shares Outstanding	4.277B shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$561.1K	$69.15K	$48.82K
YoY Change	802.35%	-94.34%	-93.75%
Cash & Equivalents	$561.1K	$69.15K	$48.82K
Short-Term Investments			$0.00
Other Short-Term Assets	$67.69K	$18.82K	$17.24K
YoY Change	61.87%	-72.05%	-88.6%
Inventory
Prepaid Expenses	$44.16K	$49.33K	$29.73K
Receivables	$287.3K	$337.7K	$176.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$960.2K	$475.0K	$271.8K
YoY Change	224.35%	-63.26%	-70.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.962M	$3.095M	$3.013M
YoY Change	-36.37%	6.91%	4.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.730K	$5.030K	$5.120K
YoY Change	-7.07%	-3.82%	0.59%
Total Long-Term Assets	$5.769M	$6.058M	$6.283M
YoY Change	-9.3%	108.86%	117.59%
TOTAL ASSETS
Total Short-Term Assets	$960.2K	$475.0K	$271.8K
Total Long-Term Assets	$5.769M	$6.058M	$6.283M
Total Assets	$6.729M	$6.533M	$6.554M
YoY Change	1.09%	55.8%	71.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$351.4K	$380.9K	$438.5K
YoY Change	-60.05%	-49.76%	-47.17%
Accrued Expenses	$275.4K	$263.8K	$241.1K
YoY Change	19.64%
Deferred Revenue
YoY Change
Short-Term Debt	$317.6K	$323.5K	$122.2K
YoY Change	-95.87%	-95.86%	-98.29%
Long-Term Debt Due	$3.552M	$3.907M	$4.029M
YoY Change	-15.19%	796.91%	1378.61%
Total Short-Term Liabilities	$14.02M	$14.02M	$13.52M
YoY Change	-10.9%	-3.53%	-2.51%
LONG-TERM LIABILITIES
Long-Term Debt	$630.6K	$658.6K	$726.4K
YoY Change	-6.6%	-85.59%	-84.15%
Other Long-Term Liabilities	$1.280M	$1.353M	$1.493M
YoY Change	-17.7%
Total Long-Term Liabilities	$2.127M	$2.247M	$2.493M
YoY Change	-4.63%	-50.83%	-45.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.02M	$14.02M	$13.52M
Total Long-Term Liabilities	$2.127M	$2.247M	$2.493M
Total Liabilities	$16.15M	$16.27M	$16.01M
YoY Change	-15.41%	-17.85%	-16.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.06M	-$44.52M	-$44.10M
YoY Change
Common Stock	$37.29M	$37.29M	$35.79M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.70M	-$10.98M	-$10.68M
YoY Change
Total Liabilities & Shareholders Equity	$6.729M	$6.533M	$6.554M
YoY Change	1.09%	55.8%	71.47%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	$512.1K	-$193.8K	$1.901M
YoY Change	-66.98%	-92.62%	-87.0%
Depreciation, Depletion And Amortization	$136.6K	$134.2K	$134.2K
YoY Change	8.46%	305.56%	352.02%
Cash From Operating Activities	$772.2K	$316.0K	-$161.5K
YoY Change	68.13%	-203.34%	-148.42%
INVESTING ACTIVITIES
Capital Expenditures	-$71.37K	-$140.9K	-$101.6K
YoY Change	128.68%
Acquisitions
YoY Change
Other Investing Activities	-$50.00K	$0.00	$0.00
YoY Change	-186.49%	-100.0%	-100.0%
Cash From Investing Activities	-$121.4K	-$140.9K	-$101.6K
YoY Change	-556.45%	-12.94%	-85.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	265.9K	80.41K	218.0K
YoY Change	-183.34%	-80.49%	-48.18%
NET CHANGE
Cash From Operating Activities	772.2K	316.0K	-161.5K
Cash From Investing Activities	-121.4K	-140.9K	-101.6K
Cash From Financing Activities	265.9K	80.41K	218.0K
Net Change In Cash	916.7K	255.6K	-45.10K
YoY Change	449.74%	-560.62%	-170.78%
FREE CASH FLOW
Cash From Operating Activities	$772.2K	$316.0K	-$161.5K
Capital Expenditures	-$71.37K	-$140.9K	-$101.6K
Free Cash Flow	$843.6K	$456.9K	-$59.86K
YoY Change	71.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000792935
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2021Q4	grst	Receivables Funding ReceivablesFunding		usd
CY2021Q2	us-gaap	Management Fee Expense ManagementFeeExpense		usd
	us-gaap	Management Fee Expense ManagementFeeExpense		usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	grst	Noncash Interest Converted To Equity NoncashInterestConvertedToEquity		usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2022Q2	grst	Penalty On Convertible Note PenaltyOnConvertibleNote		usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments		usd
CY2021Q2	grst	Penalty On Convertible Note PenaltyOnConvertibleNote		usd
	grst	Penalty On Convertible Note PenaltyOnConvertibleNote		usd
CY2022Q2	grst	Loss On Advance LossOnAdvance		usd
	grst	Loss On Advance LossOnAdvance		usd
CY2022Q2	grst	Fair Value Of Warrants Granted To Convertible Debt Holder FairValueOfWarrantsGrantedToConvertibleDebtHolder		usd
CY2021Q2	grst	Fair Value Of Warrants Granted To Convertible Debt Holder FairValueOfWarrantsGrantedToConvertibleDebtHolder		usd
	grst	Fair Value Of Warrants Granted To Convertible Debt Holder FairValueOfWarrantsGrantedToConvertibleDebtHolder		usd
	grst	Fair Value Of Warrants Granted To Convertible Debt Holders1 FairValueOfWarrantsGrantedToConvertibleDebtHolders1		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable		usd
	us-gaap	Unrealized Loss On Foreign Currency Derivatives Before Tax UnrealizedLossOnForeignCurrencyDerivativesBeforeTax		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	18819	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	17235	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	grst	Deferred Taxation Movement DeferredTaxationMovement		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	grst	Proceeds From Government Assistance Loans ProceedsFromGovernmentAssistanceLoans		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	grst	Repayment Of Finance Leases RepaymentOfFinanceLeases		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	grst	Repayment Of Receivables Funding RepaymentOfReceivablesFunding		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	grst	Conversion Of Convertible Notes ConversionOfConvertibleNotes		usd
	grst	Fair Value Of Warrant Issued FairValueOfWarrantIssued		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	grst	Finance Lease Cost FinanceLeaseCost		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	us-gaap	Lease Cost LeaseCost		usd
	grst	Derivative Liability Arising From Convertible Notes DerivativeLiabilityArisingFromConvertibleNotes		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54748
	dei	Entity Registrant Name EntityRegistrantName	ETHEMA HEALTH CORPORATION.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1227328
	dei	Entity Address Address Line1 EntityAddressAddressLine1	950 Evernia Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
	dei	City Area Code CityAreaCode	(416)
	dei	Local Phone Number LocalPhoneNumber	500-0020
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common shares
	dei	Trading Symbol TradingSymbol	GRST
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3729053805	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69145	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48822	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	337665	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	176011	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	49326	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	29731	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	474955	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	271799	usd
CY2022Q2	grst	Due On Sale Of Subsidiary DueOnSaleOfSubsidiary	5033	usd
CY2021Q4	grst	Due On Sale Of Subsidiary DueOnSaleOfSubsidiary	5115	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3095334	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3012663	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1431923	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1610913	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1525620	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1653816	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	6057910	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6282507	usd
CY2022Q2	us-gaap	Assets Assets	6532865	usd
CY2021Q4	us-gaap	Assets Assets	6554306	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	380885	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	438482	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	752892	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	658836	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	5012407	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	4891938	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	323519	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	122167	usd
CY2022Q2	grst	Mortgage Loans MortgageLoans	3742455	usd
CY2021Q4	grst	Mortgage Loans MortgageLoans	3864312	usd
CY2022Q2	grst	Federal Assistance Loans Current FederalAssistanceLoansCurrent	157367	usd
CY2021Q4	grst	Federal Assistance Loans Current FederalAssistanceLoansCurrent	157367	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	263814	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	241083	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7634	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7386	usd
CY2022Q2	grst	Receivables Funding ReceivablesFunding	184135	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	345738	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	515901	usd
CY2022Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	152607	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	105049	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	2700039	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	2514281	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14023492	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13516802	usd
CY2022Q2	grst	Federal Assistance Loansnon Current FederalAssistanceLoansnonCurrent	46562	usd
CY2021Q4	grst	Federal Assistance Loansnon Current FederalAssistanceLoansnonCurrent	47326	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	235469	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	273057	usd
CY2022Q2	grst	Third Party Loan ThirdPartyLoan	583032	usd
CY2021Q4	grst	Third Party Loan ThirdPartyLoan	646176	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	32895	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2247046	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2492885	usd
CY2022Q2	us-gaap	Liabilities Liabilities	16270538	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1352997	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1493431	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	28986	usd
CY2021Q4	us-gaap	Liabilities Liabilities	16009687	usd
CY2022Q2	grst	Preferred Stock Series B PreferredStockSeriesB	400000	usd
CY2021Q4	grst	Preferred Stock Series B PreferredStockSeriesB	400000	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	40000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	40000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3729053805	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3729053805	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3579053805	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3579053805	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	37290539	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	35790539	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22791350	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22791350	usd
CY2022Q2	grst	Discount For Shares Issued Below Par Value DiscountForSharesIssuedBelowParValue	-27363367	usd
CY2021Q4	grst	Discount For Shares Issued Below Par Value DiscountForSharesIssuedBelowParValue	-26013367	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	778180	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Before Tax1 AccumulatedOtherComprehensiveIncomeLossBeforeTax1	816532	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44520889	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44103311	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-10984187	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-10678257	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	846514	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	822876	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10137673	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9855381	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6532865	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6554306	usd
CY2022Q2	us-gaap	Revenues Revenues	1138032	usd
CY2021Q2	us-gaap	Revenues Revenues	96158	usd
	us-gaap	Revenues Revenues	2161347	usd
	us-gaap	Revenues Revenues	186951	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	261528	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2963	usd
CY2021Q2	grst	Rent Expense RentExpense	1012	usd
	grst	Rent Expense RentExpense	199539	usd
	grst	Rent Expense RentExpense	2512	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	471460	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8466	usd
CY2022Q2	grst	Rent Expense RentExpense	109508	usd
CY2022Q2	us-gaap	Management Fee Expense ManagementFeeExpense	30000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	60000	usd
CY2022Q2	grst	Professional Fee ProfessionalFee	112149	usd
CY2021Q2	grst	Professional Fee ProfessionalFee	-52744	usd
	grst	Professional Fee ProfessionalFee	161736	usd
	grst	Professional Fee ProfessionalFee	-52708	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	438842	usd
CY2021Q2	us-gaap	Salaries And Wages SalariesAndWages	46275	usd
	us-gaap	Salaries And Wages SalariesAndWages	875667	usd
	us-gaap	Salaries And Wages SalariesAndWages	59127	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	134243	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	33108	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	266243	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	65233	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1086270	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	30614	usd
	us-gaap	Operating Expenses OperatingExpenses	2034645	usd
	us-gaap	Operating Expenses OperatingExpenses	82630	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	51762	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	65544	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	126702	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	104321	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1045	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11063	usd
	grst	Penalty On Convertible Note PenaltyOnConvertibleNote	9240	usd
CY2021Q2	grst	Loss On Advance LossOnAdvance	120000	usd
	grst	Loss On Advance LossOnAdvance	120000	usd
	grst	Fair Value Of Warrants Granted To Convertible Debt Holder FairValueOfWarrantsGrantedToConvertibleDebtHolder	976788	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	122848	usd
CY2021Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	474008	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	203616	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	737988	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	211202	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	847865	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	464034	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1350542	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-67039	usd
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1146864	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	130437	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1723619	usd
CY2022Q2	grst	Foreign Exchange Movements ForeignExchangeMovements	-193368	usd
CY2021Q2	grst	Foreign Exchange Movements ForeignExchangeMovements	101247	usd
	grst	Foreign Exchange Movements ForeignExchangeMovements	-97812	usd
	grst	Foreign Exchange Movements ForeignExchangeMovements	180738	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-154914	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2626438	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-301636	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4994594	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24700	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42963	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-179614	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-2626438	usd
	us-gaap	Profit Loss ProfitLoss	-344599	usd
	us-gaap	Profit Loss ProfitLoss	-4994594	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14176	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	23638	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-193790	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2626438	usd
	us-gaap	Net Income Loss NetIncomeLoss	-368237	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4994594	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24728	usd
CY2021Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	19232	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	49341	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	50079	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-218518	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2645670	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-417578	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5044673	usd
CY2022Q2	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther	72869	usd
CY2021Q2	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther	-35311	usd
	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther	38352	usd
	us-gaap	Deferred Policy Acquisition Cost Foreign Currency Translation Adjustment And Other DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther	-64917	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-291387	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2610359	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-455930	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4979756	usd
CY2022Q2	grst	Basic And Diluted BasicAndDiluted	-0.00
CY2021Q2	grst	Basic And Diluted BasicAndDiluted	-0.00
	grst	Basic And Diluted BasicAndDiluted	-0.00
	grst	Basic And Diluted BasicAndDiluted	-0.00
CY2022Q2	grst	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	3729053805	shares
CY2021Q2	grst	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	2397374825	shares
	grst	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	3680158777	shares
	grst	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	2271234382	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9855381	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	150000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	34517	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-164985	usd
CY2022Q1	grst	Dividends Accrued DividendsAccrued	-24613	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15026099	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9860462	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-72869	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-179614	usd
CY2022Q2	grst	Dividends Accrued DividendsAccrued	-24728	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10137673	usd
CY2021Q1	grst	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	1207214	usd
CY2021Q1	grst	Warrants Exercised WarrantsExercised	90000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1271785	usd
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	29606	usd
CY2021Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2368156	usd
CY2021Q1	grst	Dividends Accrued DividendsAccrued	-30847	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14826497	usd
CY2021Q2	grst	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	677700	usd
CY2021Q2	grst	Warrants Exercised WarrantsExercised	86823	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1359622	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	35311	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2626438	usd
CY2021Q2	grst	Dividends Accrued DividendsAccrued	-19232	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15312711	usd
	us-gaap	Profit Loss ProfitLoss	-344599	usd
	us-gaap	Profit Loss ProfitLoss	-4994594	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	266243	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65233	usd
	grst	Noncash Interest Converted To Equity NoncashInterestConvertedToEquity	344701	usd
	grst	Fair Value Of Warrants Granted To Convertible Debt Holders1 FairValueOfWarrantsGrantedToConvertibleDebtHolders1	976788	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	464034	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	1350542	usd
	us-gaap	Unrealized Loss On Foreign Currency Derivatives Before Tax UnrealizedLossOnForeignCurrencyDerivativesBeforeTax	39468	usd
	grst	Derivative Liability Movements DerivativeLiabilityMovements	130437	usd
	grst	Derivative Liability Movements DerivativeLiabilityMovements	-1723619	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	128195	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	169211	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	21181	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-83840	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	104282	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1544	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-117703	usd
	grst	Deferred Taxation Movement DeferredTaxationMovement	37588	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	104905	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	25501	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	246940	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-383358	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	213726	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	498020	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-213726	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-498020	usd
	grst	Repayment Of Mortgage RepaymentOfMortgage	59761	usd
	grst	Repayment Of Mortgage RepaymentOfMortgage	58449	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1262149	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	278467	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	709778	usd
	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	160000	usd
	grst	Proceeds From Government Assistance Loans ProceedsFromGovernmentAssistanceLoans	173406	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	78646	usd
	grst	Repayment Of Finance Leases RepaymentOfFinanceLeases	3661	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	195500	usd
	grst	Repayment Of Receivables Funding RepaymentOfReceivablesFunding	15000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	207294	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	23974	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	127259	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	691302	usd
	grst	Effect Of Exchanges Rate On Cash EffectOfExchangesRateOnCash	-140150	usd
	grst	Effect Of Exchanges Rate On Cash EffectOfExchangesRateOnCash	133230	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20323	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-56846	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48822	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90500	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69145	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33654	usd
	us-gaap	Interest Paid Net InterestPaidNet	86733	usd
	us-gaap	Interest Paid Net InterestPaidNet	303336	usd
	grst	Conversion Of Convertible Notes ConversionOfConvertibleNotes	150000	usd
	grst	Fair Value Of Warrant Issued FairValueOfWarrantIssued	908126	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_z89QsmVbQpR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zszCpOlqKXf">Nature of business</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 22.5pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Since 2010, the Company has operated addiction treatment centers. Initially the Company operated an addiction treatment center in Ontario Canada under its Greenestone Muskoka clinic, which was sold on February 14, 2017. Simultaneously with this sale the Company purchased buildings and operated an addiction treatment center in Delray Beach Florida under its Addiction recovery Institute of America subsidiary with a license obtained in December 2016, initially though owned properties in Delray Beach and subsequently though leased properties in West Palm Beach, Florida. Since June 30, 2020, the Company has been actively involved in the management of a treatment center operated by Evernia in West Palm Beach Florida. On July 1, 2021, the Company closed on the acquisition of 75% of ATHI, which owns 100% of Evernia, once the probationary approval of a license was obtained from the Department of Children and Family Services of Florida. Evernia is the only active treatment center operated by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company also owns the real estate on which its Greenstone Muskoka clinic operated. The current tenant operates an addiction treatment center on these premises. The Company collects rent on this property, which is treated as a separate business segment.<b> </b></span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zYqrWkywnR43" style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.5pt 0 22.5pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a)</b></span></td> <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zzwINe10Frsd">Use of Estimates</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include valuing equity securities issued in share-based payment arrangements, determining the fair value of assets acquired, allocation of purchase price, impairment of long-lived assets, the collectability of receivables, leasing arrangements, convertible debentures, contingencies and the value of deferred taxes and related valuation allowances. Certain estimates, including evaluating the collectability of receivables and advances, could be affected by external conditions, including those unique to the Company’s industry and general economic conditions. It is possible that these external factors could have an effect on the Company’s estimates that could cause actual results to differ from the Company’s estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and record adjustments when necessary.</span></p>
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	460000	usd
CY2022Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	337665	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	176011	usd
	grst	Working Capital Deficiency WorkingCapitalDeficiency	13500000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	345738	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44520889	usd
CY2022Q2	grst	Business Acquisition Cash Consideration BusinessAcquisitionCashConsideration	50000	usd
CY2022Q2	grst	Shares Of Common Stock At Fair Market Value SharesOfCommonStockAtFairMarketValue	410000	usd
CY2022Q2	grst	Total Purchase Consideration TotalPurchaseConsideration	460000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	60324	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	198133	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	130234	usd
CY2022Q2	grst	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Right Of Use Asset BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset	1772560	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	1789903	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	3951154	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities	50040	usd
CY2022Q2	grst	Intercompany Advance IntercompanyAdvance	-1140985	usd
CY2022Q2	grst	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities	-1836151	usd
CY2022Q2	grst	Imputed Deferred Taxation On Identifiable Intangible Acquired ImputedDeferredTaxationOnIdentifiableIntangibleAcquired	-310645	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	3337821	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	613333	usd
CY2022Q2	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	153333	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1973302	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	94553	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1268660	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-5367301	usd
	grst	Calculated Stock Price Maximum CalculatedStockPriceMaximum	0.0010
	grst	Expected Life Of Convertible Notes And Warrants Minimum ExpectedLifeOfConvertibleNotesAndWarrantsMinimum	P3M
	grst	Expected Life Of Convertible Notes And Warrants Maximum ExpectedLifeOfConvertibleNotesAndWarrantsMaximum	P36M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5595	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1279	usd
	grst	Finance Lease Cost FinanceLeaseCost	6874	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	199539	usd
	us-gaap	Lease Cost LeaseCost	206413	usd
	grst	Principal Principal	4399332	usd
	grst	Accrued Interest AccruedInterest	796315	usd
	grst	Unamortized Discount UnamortizedDiscount	-183239	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3811938	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	716604	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3095334	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3012663	usd
	us-gaap	Depreciation Depreciation	266243	usd
	us-gaap	Depreciation Depreciation	65233	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1789903	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	357980	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1431923	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1610913	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	178990	usd
CY2022Q2	grst	Rightofuse Assets Finance Leases Net Of Depreciation Included In Property And Equipment RightofuseAssetsFinanceLeasesNetOfDepreciationIncludedInPropertyAndEquipment	43673	usd
CY2021Q4	grst	Rightofuse Assets Finance Leases Net Of Depreciation Included In Property And Equipment RightofuseAssetsFinanceLeasesNetOfDepreciationIncludedInPropertyAndEquipment	49268	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1525620	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1653816	usd
CY2021Q4	grst	Hstgst Payable HstgstPayable	123134	usd
	grst	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	-3661	usd
	grst	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	-199539	usd
	grst	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	-203200	usd
	grst	Weighted Average Lease Term Finance Leases WeightedAverageLeaseTermFinanceLeases	4 years and three months
	grst	Weighted Average Remaining Lease Term Operating Leases In Years WeightedAverageRemainingLeaseTermOperatingLeasesInYears	4 years and 7 months
CY2022Q2	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.0661	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0464	pure
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4915	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	9829	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	9829	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	9829	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	7902	usd
CY2022Q2	grst	Total Undiscounted Minimum Future Lease Payment TotalUndiscountedMinimumFutureLeasePayment	42304	usd
CY2022Q2	grst	Imputed Interest ImputedInterest	5684	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	36620	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7634	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	28986	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	36620	usd
CY2022Q2	grst	Income Tax Payable IncomeTaxPayable	466018	usd
CY2021Q4	grst	Income Tax Payable IncomeTaxPayable	391682	usd
CY2022Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	752892	usd
CY2021Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	658836	usd
CY2022Q2	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	166698	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	348677	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	366110	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	384416	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	437407	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1703308	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	86497	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1616811	usd
CY2022Q2	grst	Operating Leases Liability Current OperatingLeasesLiabilityCurrent	263814	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1352997	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1616811	usd
CY2022Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	141696	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	144020	usd
CY2022Q2	grst	Hstgst Payable HstgstPayable	145178	usd
CY2022Q2	grst	Total Total	5012407	usd
CY2021Q4	grst	Total Total	4891938	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	345738	usd
	grst	Calculated Stock Price Minimum CalculatedStockPriceMinimum	0.0006
CY2021Q4	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	515901	usd
CY2020Q4	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	4765387	usd
	grst	Marktomarket Adjustments On Converted Notes MarktomarketAdjustmentsOnConvertedNotes	-39726	usd
CY2021	grst	Marktomarket Adjustments On Converted Notes MarktomarketAdjustmentsOnConvertedNotes	-2914119	usd
CY2021	grst	Derivative Liability Arising From Convertible Notes DerivativeLiabilityArisingFromConvertibleNotes	190824	usd
	grst	Fair Value Adjustment To Derivative Liability FairValueAdjustmentToDerivativeLiability	-130437	usd
CY2021	grst	Fair Value Adjustment To Derivative Liability FairValueAdjustmentToDerivativeLiability	-1526191	usd
CY2022Q2	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	345738	usd
CY2021Q4	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	515901	usd
CY2022Q2	grst	Warrants Outstanding WarrantsOutstanding	605727506	shares
CY2022Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y2M26D
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0018692
CY2022Q2	grst	Warrants Exercisable WarrantsExercisable	605727506	shares
CY2022Q2	grst	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercisable ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisable	0.0018692
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	929744111	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2063677294	shares

Files In Submission

Name	View Source	Status
0001903596-22-000529-index-headers.html	Edgar Link	pending
0001903596-22-000529-index.html	Edgar Link	pending
0001903596-22-000529.txt	Edgar Link	pending
0001903596-22-000529-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
grst-20220630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
grst-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
grst-20220630_cal.xml	Edgar Link	unprocessable
grst-20220630_pre.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfsgrst10q051122ex31.htm	Edgar Link	pending
sfsgrst10q051122ex32.htm	Edgar Link	pending
sfsgrst10q081122.htm	Edgar Link	pending
Show.js	Edgar Link	pending
grst-20220630_lab.xml	Edgar Link	unprocessable
sfsgrst10q081122_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRST
ETHEMA HEALTH Corp Stock $grst

2022 Q3 Form 10-Q Financial Statement

#000190359622000529 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRST ETHEMA HEALTH Corp Stock $grst

2022 Q3 Form 10-Q Financial Statement

#000190359622000529 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRST
ETHEMA HEALTH Corp Stock $grst